(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Poster Session A: Prostate Cancer. Dr. Moein Moradpour ...

The approval of ¹⁷⁷Lu-PSMA-617 for adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) previously treated with androgen receptor pathway inhibitors and ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

TUESDAY, Feb. 4, 2025 (HealthDay News) -- It’s tough for a man to know what to do following a diagnosis of prostate cancer.

There are self-care strategies that may aid in helping to prevent prostate cancer, the second most common cause of cancer-related death in men. Located below the bladder, the prostate is the gland ...

Lupron Depot (leuprolide acetate) is a prescription drug used to treat advanced prostate cancer and other conditions. The drug is given as an injection into a muscle. The dosage you’re ...

Cancer does not discriminate, except when it does. Prostate cancer takes a harsher toll on Black men than other American men. Black men are almost 70% more likely than white men to develop prostate ...